Evaluation of the potential carcinogenicity of acetamide, n-fluoren-2-yl (53-96-3). Final report

Technical Report · Wed Jun 01 00:00:00 EDT 1988

OSTI ID:6431983

Acetamide, N-Fluoren-2-yl is a probable human carcinogen, classified as weight-of-evidence Group B2 under the EPA Guidelines for Carcinogen Risk Assessment. Evidence on potential carcinogenicity from animal studies is Sufficient, and the evidence from human studies is No Data. The potency factor (F) for acetamide, N-fluoren-2-yl is estimated to be 148/(mg/kg/day), placing it in potency group 1 according to the CAG's methodology for evaluating potential carcinogens. Combining the weight-of-evidence group and the potency group, acetamide, N-fluoren-2-yl is assigned a HIGH hazard ranking for the purposes of RQ adjustment.

• Research Organization: Syracuse Research Corp., NY (United States)
• OSTI ID: 6431983
• Report Number(s): PB-93-181626/XAB; CNN: EPA-68-03-3112; EPA-68-03-3182
• Country of Publication: United States
• Language: English

Related Subjects

29 ENERGY PLANNING, POLICY, AND ECONOMY
290300 -- Energy Planning & Policy-- Environment
Health
& Safety
560300* -- Chemicals Metabolism & Toxicology
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
ACETAMIDE
AMIDES
ANIMALS
CARCINOGENS
DOCUMENT TYPES
DOSE-RESPONSE RELATIONSHIPS
HUMAN POPULATIONS
NATIONAL ORGANIZATIONS
ORGANIC COMPOUNDS
ORGANIC NITROGEN COMPOUNDS
POPULATIONS
REGULATORY GUIDES
RISK ASSESSMENT
TOXICITY
US EPA
US ORGANIZATIONS
WEIGHT